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Abstract: Phycobiliproteins (PBPs) are the main component of light-harvesting complexes in 
cyanobacteria and red algae. In addition to their important role in photosynthesis, PBPs have 
many potential applications in foods, cosmetics, medical diagnosis and treatment of diseases. 
However, basic researches and technological innovations are urgently needed for exploring 
those potentials, such as structure and function, their biosynthesis as well as downstream 
purification. For medical use and application, mechanisms underlying their therapeutic effects 
must be elucidated. Focusing on these issues, this article gives a critical review on the current 
status on PBPs, including their structures and functions, preparation processes and 
applications. In addition, key technical challenges and possible solutions are prospected. 
Keywords: Phycobiliprotein; Structure and function; Biosynthesis; Purification; Oxidative stress; 
Anti-tumor effect 
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1. Introduction 
Oxygenic photosynthesis is an ancient and important biochemical process. Solar energy at 
wavelengths of 400–700 nm (photosynthetically active radiation) is captured by 
photosynthetic organisms and converted into chemical energy that can be used directly by 
living cells. Different from higher plants and green algae, major light-harvesting antennae in 
cyanobacteria and red algae are a large multi-subunit protein complex called phycobilisome 
(PBS), which was discovered in the 1960s (Gantt and Conti, 1965, 1966). PBSs, which 
harvest solar energy and transfer it into photosystems with extremely high efficiency, can be 
classified into three morphological types: hemi-ellipsoidal, hemi-discoidal, and bundle shaped 
(Gantt and Lipschultz, 1972; Guglielmi et al., 1981; Elmorjani et al., 1986; Glauser et al., 
1992). All three types of PBSs are composed of water-soluble phycobiliproteins (PBPs) and 
hydrophobic linker peptides (Liu, 2016). 
PBPs are a group of disk-shaped macromolecular proteins with covalently attached 
open-chain tetrapyrroles known as phycobilins (Apt et al., 1995). The structure, function, and 
application of PBPs have been studied intensively since their discovery (Guan et al., 2013). 
Recently, a PBS with molecular mass of 16.8 MDa was collected from the red alga Griffithsia 
pacifica, and its structure was deciphered by single-particle cryo-electron microscopy (Zhang 
et al., 2017). This is the first high-resolution molecular structure of PBS with a resolution of 
3.5 Å, through which how PBSs are assembled from PBPs and linker peptides was elucidated, 
and several putative energy transfer pathways were speculated. 
In addition to be used as natural pigments in food, cosmetics, dyes and so on, PBPs have 
been proven to have anti-oxidative, anti-viral, anti-tumor, immunity enhancing, and 
anti-inflammatory effects (Romay et al., 2003; Eriksen, 2008; Kuddus et al., 2013; 
Manirafasha et al., 2016). Therefore, PBPs, as physiologically active substances, have 
potential medicinal applications. Besides, PBPs have been also widely used as fluorescent 
labeling probes or photosensitizers in anti-tumor research (Fernandez-Rojas et al., 2014). 
However, extending the application of PBPs depends on a comprehensive understanding of 
their structures and spectral properties. 
Current research on PBPs mainly focuses on the following aspects: 1) their structures, 
functions and biosynthesis, 2) mechanism underlying of the energy transfer in PBPs, 3) 
methods for their preparation, and 4) their potential applications, which are critically reviewed 
in this article. 
 
2. PBPs 
2.1. Types of PBPs 
PBPs can be classified into four types according to their spectral properties: phycoerythrin 
(PE), phycocyanin (PC), allophycocyanin (APC), and phycoerythrocyanin (PEC) (Apt et al., 
1995; MacColl, 1998). In early research, prefixes to PC and PE were used to distinguish their 
taxonomic origins. For example, R- was derived from red algae, while C- denoted those 
derived from cyanobacteria. 
With improved understanding of PBPs, researchers found that PBPs from different 
sources could share similar spectral properties. For example, the spectral properties of PC 
from some red algae are similar to those from cyanobacteria. Therefore, nowadays prefixes 
are used to denote spectral properties rather than taxonomic sources (Table 1). Based on the 
absorption and fluorescence spectra, PE can be divided into R-PE, B-PE, b-PE and C-PE; PC 
can be divided into R-PC and C-PC. According to differences in PBPs with specific light 
spectra, R-PE can be further divided into four sub-types: R-PE I to IV; C-PE can be divided 
into C-PE I and II; and R-PC can be divided into R-PC I and II, and other types (Kursar et al., 
1983; Tandeau, 2003). 
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Table 1 
 
2.2. Structures and functions 
2.2.1. Structures 
In the past decades, crystal structures of PBPs from various sources have been resolved. The 
basic building block of PBPs is a monomer comprising α and β subunits, each with a 
molecular mass from 15 to 20 kDa for 160 - 165 amino acids. 
The monomers oligomerize into (αβ)3 trimer in a face-to-face to form with C3 symmetry. 
Two (αβ)3 form an (αβ)6 hexamer structure with three-fold symmetry. In PE, an additional γ 
subunit generally binds to one (αβ)6 moiety, resulting in a more stable PBP. In cyanobacteria 
and red algae, PBP trimers or hexamers assemble into PBS with the assistance of linker 
peptides. However, in Cryptophyta, PBPs exist as (αβ)2 unit, and do not form into higher 
aggregation state (Anwer et al., 2015). 
The aggregation state of isolated PBP is related to its concentration, pH value and ions in 
solution (Anwer et al., 2015). A dynamic equilibrium between different aggregated states of 
PBPs is present in solution. Dissociation of (αβ)3 and (αβ)6 units during the purification 
process usually lead to a blue-shift of the fluorescent peak (Kupka and Scheer, 2008). When 
genes encoding α and β subunits of PBP in Synechocystis sp. PCC 6803 were expressed in E. 
coli, the subunits were found to self-assemble into trimmers (Liu et al., 2010). One prominent 
spectroscopic characteristic of recombinant APC is its strong red-shift in the absorption and 
emission maxima when the monomers are assembled into a trimer, which was the first report 
of the assembly of recombinant ApcA and ApcB into a trimer with the native structure (Adir 
et al., 2006). Because PBPs have a higher molar extinction coefficient, they are widely used in 
fluorescence microscopy and immunoassays. However, the spectral characteristics of purified 
PBPs usually depend on their aggregation states. If PBPs lose their higher order protein 
structures, their absorption and fluorescence properties may be diminished, even completely 
lost. 
The absorption properties of PBPs are attributed to the presence of open-chain 
tetrapyrrole chromophores called phycobilins, which include phycocyanobilin (PCB, Amax = 
640 nm), phycoerythrobilin (PEB, Amax = 550 nm), phycouroblilin (PUB, Amax = 490 nm), 
and phycoviolobilin (PXB, Amax = 590 nm). Two bilins are linked to conserved cysteine 
residues at position 84 to the α and β subunits, while other pigments (if present) are bound at 
additional cysteine sites (α75, α140, β50/61, β155, etc) (Glazer, 1994; Apt et al., 1995; 
MacColl, 1998; MacColl et al., 1999; Sonani et al., 2015). 
 
2.2.2. Optical properties 
Water presents a different light environment. The reason for this is that the preferential 
absorption of long wavelength photons with low energy such as red light mainly determines 
the spectral distribution of light attenuation, but short wavelength blue photons with high 
energy can penetrate the depth. As a result, deep water is full of blue-green light. Many small 
cyanobacteria and red algae can survive in the light environment less than 1% surface 
irradiance, and some much smaller microalgae may require light irradiance as low as 0.1%, 
even less, because PBPs can efficiently capture and transmit light energy in deep-water areas, 
in particular, the blue-green light that can penetrated into deep water. Interestingly, 
cyanobacteria exhibit a form of photomorphogenesis termed chromatic acclimation (CA), and 
one of the characteristics of CA is to regulate the pigment composition of PBP to optimize 
light absorption for photosynthesis, thus adapting to the special light environment in water 
(Montgomery, 2017). 
The four PBPs can be divided into three types according to energy levels associated with 
light absorption: high energy (PE and PEC), medium energy (PC) and low energy (APC). The 
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absorption and fluorescence emission spectra of PBPs with different energy levels have a 
strong overlap (Fig. 1), an denergy is transferred in the PBS progress from PE, PC and APC to 
the photosynthetic reaction center: light energy absorbed by phycobilins is transmitted first 
between the subunits, then between different PBPs and finally to the reaction center located in 
the thylakoid membrane. The efficiency of this energy transfer is higher than 95% (Sidler, 
1994; Onishi et al., 2015; Zhang et al., 2015). PBPs have the advantages of high water 
solubility, non-toxicity, high fluorescence quantum yield, Stokes shift and slowness in 
fluorescence quenching. In addition, the spectral properties and quantum yield are generally 
maintained after cross-linking with other proteins. Therefore, in the 1980s, Glazer first 
proposed that PBPs could be used as fluorescent probes (Oi et al., 1982), leading to 
applications of PBPs in clinical diagnostic chemistry (Glazer and Stryer, 1984). 
 
Figure 1 
 
3. Production of PBPs 
Methods for purifying PBPs vary depending on cyanobacteria or algal source. In general, two 
steps are involved: extraction of crude protein and PBP purification. Different methods have 
significantimpact on the purity and activity of PBPs. The purity of PBPs is usually expressed 
by the ratio Amax/A280. 
 
3.1. Cell disruption and crude PBP extraction 
PBPs are water-soluble intracellular proteins. The first step for preparing PBPs is to choose 
technique to release PBPs from cells, and in the meantime maintains their structures and 
functions unaffected significantly. In general, the higher the proportion of broken algal cells is, 
the higher the yield of PBPs will be. However, violent disruption may have negative effect on 
the structures and functions of the PBPs. Common methods for cell disruption include 
mechanical (grinding, high-pressure homogenization, ultrasonication, etc) and 
non-mechanical ones (repeated freezing and thawing, lysozyme treatment, osmotic shock, etc) 
(Sekar and Chandramohan, 2007). 
Freezing-thawing: Freezing-thawing treatment is among the most widely used methods 
for extracting PBPs, which is very effective for most cyanobacteria and some red algae. After 
treatment with freezing and thawing, the permeation barrier of cells is damaged and internal 
materials are released (Calcott and MacLeod, 1975). Generally, cyanobacteria or red algae are 
frozen at about –20 °C for several hours, and then thawed at 4°C or room temperature. For a 
better extracting efficiency, several rounds of freezing-thawing are usually used. 
Sonication: Sonication is a time-saving method for destructing cell structures by creating 
violent blast pressure in solutions (Le Guillard et al., 2015; Mittal et al., 2017), which is 
widely used in laboratory for disrupting cyanobacteria or single-celled red algae with high 
efficiency. However, this method is not considered to be suitable for the large scale extraction 
of PBPs, because it is difficult to transmit sufficient energy to large volumes of cell 
suspension (Balasundaram et al., 2009). Moreover, the energy of ultrasound waves could be 
transformed into heat, which may influence the stability of the protein structure. 
Osmotic shock: Fresh cyanobacteria or red algae could be mixed with distilled water or 
extracting buffers and kept in dark for hours. This would induce cell lysis by hypotonicity. In 
some reports, cyanobacteria or red algae were freeze-dried before mixing with distilled water 
or extracting buffers, which would enhance productivity for the crude extract (Kissoudi et al., 
2018). 
Selection of proper extraction methods depends on cyanobacterial or red algal species. A 
comparison for extracting C-PC from S. platensis showed that extraction efficiency with the 
methods of repeated freezing-thawing, lysozyme treatment, and bacteria (Klebsiella 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 6 
pneumoniae) treatment was comparable, but glass bead grinding and sonication were not 
efficient (Zhu et al., 2007). Another work compared different methods for extracting PBPs 
from the red alga Porphyridium cruentum, and the authors considered that buffer extraction 
from lyophilized alga was better than other methods such as repeated freezing-thawing and 
sonication (Bermejo et al., 2003). To enhance the extraction, a combination of several 
methods is usually used in laboratory. 
 
3.2. Purification of PBPs 
The concentration of PBPs in crude extract is relatively low. Therefore, further work must be 
carried out to improve the purity of the PBPs. The procedure of purification often involves 
several steps. The most commonly used methods include ammonium sulfate fractionation, 
chromatographic separation and two-phase aqueous extraction. 
Ammonium sulfate fractionation is widely used in PBP purification before further 
treatment. The colloidal stability of the protein surface could be disrupted by increasing 
ammonium concentration in the solution (Burgess, 2009). Usually, ammonium sulfate 
fractionation involves two steps: the first step is to precipitate impurities with 20-30% (w/v) 
ammonium sulfate, which can be removed by centrifugation, and the second step is to 
precipitate most PBPs from the supernatant by further increasing ammonium sulfate to 
60-70% (w/v). Ammonium sulfate fractionation treatment could help to remove large amounts 
of impurities. Therefore, this treatment is recommended for PBP purification. 
Various chromatographic technologies have been developed for purifying PBPs, 
including gel filtration chromatography, ion exchange chromatography, hydroxyapatite 
chromatography, expanded bed adsorption chromatography, hydrophobic interaction 
chromatography, etc. Gel filtration chromatography, also known as size-exclusion 
chromatography, separates proteins mainly based on their sizes. Ion exchange 
chromatography separates proteins mainly based on their affinity to ions. These two 
chromatographic methods are most commonly used when purifying PBPs in laboratory. 
Several reports showed that APC could only be separated with high efficiency from other 
PBPs by ion exchange chromatography (Yan et al., 2011; Sorensen et al., 2013). Most ion 
exchange chromatographic separation works through a gradient of ionic strength when 
purifying PBPs. However, advances indicate that an elution method with a gradient of pH is 
quite efficient for separating PBPs (Liu et al., 2005; Su et al., 2010; Yan et al., 2011; Kumar et 
al., 2014). Expanded bed adsorption chromatography allows separating proteins directly from 
the crude extract, bypassing initial treatment such as centrifugation and ammonium sulfate 
precipitation. Therefore, this method reduced the steps used in the purification of PBPs, which 
is a time saving technique compared with other methods. 
Aqueous two-phase extraction has been widely used for separating biomolecules, which 
has been the subject of extensive studies in the purification of PBPs (Table 2). This process is 
easily to be scaled up, but less efficient compared to other separation processes such as 
chromatographic separation and purification. As a result, it is an alternative method for 
industries to obtain products at large scale with low purification cost, which may be not 
suitable for the separation of PBPs when they are developed as value-added products to be 
produced in relatively small volume. 
 
Table 2 
 
3.3. Production of recombinant PBPs 
In 1985, the APC gene of Cyanophora paradoxa and the PC gene of Synechococcus sp. 
PCC7002 were expressed in E. coli, showing the successful heterologous expression of PBPs 
using genetic engineering techniques (Bryant et al., 1985). Two processes are involved in the 
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biosynthesis of PBPs: 1) the synthesis of apoproteins and phycobilins and 2) the binding of 
phycobilins to apoproteins by enzymatic catalysis. When bacteria are engineered to produce 
recombinant PBPs, special molecular tags have often been used, which facilitate the 
purification of the recombinant PBPs (Gambetta and Lagarias, 2001; Kohchi et al., 2001; 
Zhao et al., 2005; Li et al., 2017). 
The biosynthesis of phycobilins is derived from the metabolism of heme. Heme is split 
into biliverdin by heme oxygenase (HO), and then biliverdin can be reduced by the 
phycobiferous reductase family and be further reduced to other types of phycobilin. For 
example, PCB is reduced by the reductase PcyA (Tooley et al., 2001), while the synthesis of 
PEB is catalyzed by two enzymes (PebA and Peb) (Kohchi et al., 2001). Because the 
exogenous phycocyanin-related ferredoxin oxidoreductase gene can be expressed in E. coli, 
PBPs can be produced on a large scale by biosynthesis in E. coli. (Gambetta and Lagarias, 
2001). 
After being synthesized in E. coli, phycobilins need to bind to the correct site of the 
apoprotein. This process can be catalyzed by either autocatalysis or lytic enzymes. As an 
example of the autocatalytic process, studies have shown that PCB can spontaneously form a 
pigment–protein structure in vitro with similar spectral properties to the native protein in vivo 
(Zhao et al., 2005). However, in recombinant PBPs, the linkage between a phycobilin and 
apoprotein is formed with higher efficiency and correctness when catalyzed by a lyase. 
Therefore, the use of PBP lyases is the key to synthesizing recombinant PBPs efficiently in 
vitro. Some PBP lyases are shown in Table 3. 
 
Table 3 
 
Zhao’s group has performed considerable research on recombinant PBPs (Wang et al., 
2011; Zhou et al., 2014; Dong et al., 2016), which discovered three PBP lyases and created a 
molecular design method for switching light-activated red fluorescent PBPs. Recently, this 
group reported the trimeric crystal structure of recombinant AP-B derived from Synechocystis 
sp. PCC6803, with a resolution of 1.75 Å. Both AP-B and APC are located in the core of the 
PBS, and AP-B passes the captured light energy to the photoreaction center. Because it is 
difficult to purify AP-B from natural sources, recombinant AP-B provides an effective 
approach for studying the structure, energy transfer function and applications of PBSs (Peng 
et al., 2014). 
Based on genetic engineering techniques, large-scale production of low-cost recombinant 
PBPs can be achieved. The genes of APC and PC subunits have been successfully expressed 
in E. coli or Pichia pastoris (Qin et al., 2004). Recombinant PBP subunits usually contain 
either a His tag or a maltose binding protein tag at the terminus. Therefore, the recombinant 
PBPs could be purified by affinity chromatography. Research indicated that the recombinant 
PBP subunit exhibited similar spectral characteristics as the native PBP subunit (Guan et al., 
2007; Ge et al., 2009; Li et al., 2017). By molecular design and recombinant synthesis, 
various types of PBPs with improved functions could be obtained for future applications. 
 
4. Applications of PBPs 
Although PBPs have been produced at large scale in China from Spirulina with a total 
production capacity of ~40 tons / year, few companies sell relative products in large quantities. 
This is because high value-added products based on PBPs are lacking in the market and 
current research mainly focuses on their applications in pharmaceutical and optical products 
(Fig. 2). 
 
Figure 2 
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4.1. Pharmacological applications 
Research on the physiological activity of PBPs has been carried out for more than 20 years. 
PBPs have been found to have a strong antioxidant effect through eliminating excess reactive 
oxygen species (ROS) and increasing the amount of anti-oxidative enzymes (Wu et al., 2016). 
Therefore, PBPs have potentials for treating a variety of diseases caused by oxidative stress. 
Since the antioxidant effect of PBPs was demonstrated, these proteins have been investigated 
for treating several diseases in vivo and in vitro (Fernandez-Rojas et al., 2014). Many studies 
in vitro models have also shown that PBPs have anti-inflammatory, anti-viral, anti-tumor, and 
enhanced immunity functions (Table 4). 
 
Table 4 
 
4.1.1. Antioxidant effects 
4.1.1.1. In vitro studies of antioxidant properties 
Romay et al. (1998) first reported that PBPs showed anti-oxidative properties both in vitro 
and in vivo. PC could effectively eliminate hydroxyl radicals (•OH) and alkoxy radicals (RO•) 
and inhibit lipid peroxidation. The anti-oxidative mechanism of PC was found to be similar to 
that of commonly used antioxidants such as to copherol and ascorbic acid. PC can also inhibit 
oxidative-induced hemolysis of red blood cells (Romay and Gonzalez, 2000). 
It has been proposed that both components of PBPs, the apoprotein (α and β subunits) 
and phycobilins, are involved in antioxidant effect through mechanism of stabilizing systems 
for the detoxification of ROS (Pleonsil et al., 2013). When PC was hydrolyzed with trypsin, it 
was found that the apoprotein portion of the molecule showed partial antioxidant properties 
(Zhou et al., 2005). Proteins can lose activity in the presence of sodium lauryl sulfate, urea, or 
under alkaline conditions, which may lose the ability to produce hydroxyl radicals, but the 
ability to scavenge hydroxyl radicals increases. This indicates that PCB in PBPs may play an 
important role in clearing hydroxyl radicals. Hirata et al. (2000) studied the anti-oxidative 
effect of PC using a hydrophobic system with phosphatidylcholine liposomes and showed that 
PCB had a higher antioxidant activity than tocopherol. The PCB of PC is easily oxidized. 
Micromolar concentrations of C-PC can halve the steady-state concentration of hydrogen 
peroxide radicals, and PCB might be the main target for free-radical to attack for antioxidant 
activity similar to catechin (Lissi et al., 2000). 
Light impacts the antioxidant activity of PBPs, which can produce free radicals under 
light conditions, but those free radicals can be removed under dark conditions. C-PC 
produced from Spirulina was exposed to blue and white light, and the antioxidant properties 
of C-PC under different light conditions were examined, which indicated that C-PC under 
blue light had higher oxidation resistance than under normal light. In addition, amino acid 
sequence studies of the C-PC subunits showed that blue light can result in a rearrangement of 
the positions of amino groups in the beta chain indicating a modification of the polypeptide 
with higher numbers of cysteine residues (Madhyastha et al., 2009). Huang et al. (2007) 
obtained selenium-containing PCs (Se-PCs) from selenium-rich S. platensis, and studied their 
antioxidant activities such as the ability to scavenge the free radicals of superoxide, hydrogen 
peroxide, and 2,2-diphenyl-1-picryl-hydrazyl (DPPH). The antioxidant activity of Se-PC 
toward different free radicals was different, and the ability of the Se-PCs to scavenge 
superoxide and hydrogen peroxide radicals was positively correlated with the Se content. 
When PC reacted with antioxidants, the maximum absorption peak at 620 nm disappeared, 
and in the mean time the blue color of PC gradually disappeared and the PC oxidation 
resistance decreased rapidly (Benedetti et al., 2004). 
Ge et al. (2006) expressed apo-APC and its subunits from Cyanobacteria in E. coli. and 
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used a deoxyribose assay to evaluate its antioxidant properties. The recombinant APC fused 
with a MBP tag and a 6-His tag scavenged hydroxyl radicals successfully as the α and β 
subunits could, but the α and β subunits had a higher inhibitory effect on hydroxyl radicals 
when tested separately than they were combined together, and the effect on the radical 
clearance by the subunits was improved as their concentrations of the subunits increased. 
These results showed that apo-APC was involved in the antioxidant and free-radical 
scavenging activity of PC, and indicated that antioxidant activity might be partly responsible 
for the anti-tumor effect of APC .The α subunit and the chromophore of APC in E. coli can be 
catalyzed to become holo-ApcA, which can inhibit hydroxyl and hydrogen peroxide radicals 
more strongly than ApcA and native APC (Zhang et al., 2009). Guan et al. (2009) expressed 
and produced a fluorescent antioxidant holo-alpha-PC from S. platensis with a His-tag 
(rHHPC: recombinant holo-alpha-phycocyanin of S. platensis) biosynthesized in E. coli BL21. 
The combined biosynthesis of rHHPC was successful and rHHPC was conveniently purified 
by Ni
2+
 affinity column chromatography. rHHPC was demonstrated to be effective at clearing 
hydroxyl and hydrogen peroxide radicals. The IC50 values of rHHPC were 277.5 ± 25.8 and 
20.8 ±2.2 μg/ mL for hydroxyl and peroxyl radicals, respectively. 
These studies indicate that both natural PBPs and recombinant PBPs are promising 
antioxidant with potential use in the food and pharmaceutical industries. 
 
4.1.1.2. Antioxidant effects in human and animal diseases 
Atherosclerosis: Oxidative stress involved in the development of atherosclerosis (AS) is a 
complex process. ROS and other pathogenic factors exert a synergistic effect resulting in 
microvascular damage. In addition, ROS has toxic effect on the vascular cell walls. It has 
been shown that low density lipoproteins (LDLs) and similar compounds in blood are easily 
attacked and affected by ROS when free radicals and lipid peroxidation products are increased 
in the blood of model animals and patients (Vogiatzi et al., 2009). Many enzymes contribute 
to the development of AS, including NAD oxidase, endothelial nitric oxide synthase, xanthine 
oxidase, and myeloperoxidase. In blood vessels, the main enzyme generating ROS is NAD 
oxidase. Riss et al (2007) reported that PC from Spirulina can increase the level of antioxidant 
enzymes in the body, and consequently inhibit the production of ROS, which eventually leads 
to the enhancement of plasma antioxidant capacity. PC can also reduce the expression of 
NAD oxidase to decrease ROS production, and thus ameliorate atherosclerosis caused by 
oxidative stress (Riss et al., 2007). Strasky et al. (2013) reported that PC could activate the 
expression of encoding heme oxygenase-1 to increase the enzyme’s content in the 
atherosclerotic lesion of mice with apolipoprotein E gene deletion to reduce the severity of the 
disease. This is because heme oxygenase-1 can catabolize heme to produce bilirubin, which 
has potent antioxidant capacity. PC can also regulate oxidative-stress and endothelial 
cell-dysfunction marker proteins such as endothelial nitric oxide synthase and NAD oxidase, 
and reduce atherosclerotic lesions. These studies indicate that PC can potentially treat 
atherosclerosis by attenuating the oxidative stress. 
Liver disease: Oxidative stress may induce the development of liver diseases such as 
fatty liver, viral hepatitis, and hepatic fibrosis. Research shows that increased ROS can 
deplete intracellular ATP, impair the oxidative capacity of mitochondria, and affect the 
oxidation of acetaldehyde for its accumulation in the liver. Therefore, if oxidative stress can 
be reduced, liver will be protected from the damage. (Day and James, 1998; Zhu et al., 2012). 
Pak et al. (2012) studied the effect of PC on non-alcoholic fatty liver disease which showed 
that PC has anti-oxidative and anti-inflammatory effects and can prevent the progression of 
non-alcoholic fatty liver disease. In a mouse model of non-alcoholic fatty liver, the levels of 
mitochondrial ROS and inflammatory cytokines were significantly increased, but ROS in 
mice treated with PC did not change significantly compared to that in the control, indicating 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 10 
that PC can reduce oxidative stress, inhibit inflammation, and thus treat non-alcoholic fatty 
liver disease. Xia et al. (2016) studied the protective effects of PC on alcoholic fatty liver , 
and found that PC reduced the serum levels of alanine aminotransferase, aspartate 
aminotransferase, triglyceride, total cholesterol and low-density lipoprotein, and increased the 
content of SOD and malondialdehyde (MDA) in the liver, thereby reducing oxidative stress. 
Ou et al. (2010) demonstrated that PC could reduce CCl4-induced liver damage by 
scavenging ROS and enhancing the activity of SOD and glutathione peroxidase (GSH-Px). 
Cataracts: The formation of cataracts is one of the most common eye diseases (Alfawaz 
et al., 2014; Miric et al., 2014). In recent years, some researchers have found that there is a 
correlation between occurrence in cataracts and the oxidation index. An imbalance between 
the oxidation and antioxidant systems in eyes can produce an oxidative stress response, which 
may denature the lens protein, and cause cataracts (Kaur et al., 2012). As an antioxidant, PC 
can play a role in the treatment of cataracts. Kothadia and Shabaraya (2011) found that PC 
could reduce galactose-induced cataracts by increasing the expression of glutathione (GSH) 
and eliminating free radicals. Kumari et al. (2013) used sodium selenite to induce cataracts in 
rats for PC treatment, and their results showed that PC could regulate the expression of 
antioxidant enzymes, increase the activity of antioxidant enzymes, and reduce the oxidative 
stress response. These results suggest that PBPs as antioxidant might provide an effective 
treatment for cataracts. 
Neuropathy: When oxidative stress occurs, high levels of ROS can cause lipid 
peroxidation in neuronal cell membranes, and increase their permeability. Neuronal cells are 
more likely to develop toxic edema, leading to neuronal damage (Buonocore et al., 2001). 
Min et al. (2015) demonstrated that PC protects the brain from oxidative damage. Kainic acid 
can produce a large number of oxygen free radicals, leading to epilepsy in rats. Rimbau et al. 
(1999) used kainic acid to induce epilepsy in rats and found that treating the rats with PC 
eliminated the free radicals produced by the kainic acid and protected neurons. Iron can cause 
oxidative stress in SH-SY5Y neurons. Bermejo-Bescós et al. (2008) found that PC protected 
SH-SY5Y nerve cells from oxidative stress by activating antioxidant enzymes, such as SOD, 
catalase, and glutathione peroxidase (GSH-Px), and the same study also indicated that PC 
may play a protective role in nerve injury caused by free radicals with potentials for treating 
Alzheimer’s and Parkinson’s diseases. Therefore, patients with neurological diseases might be 
treated with anti-oxidative therapy based on PBPs to achieve a better therapeutic effect. 
Kidney disease: Overproduction of ROS can damage kidneys and cause diabetes. After 
10 consecutive weeks of an oral administration of PC in mice with type-2 diabetes, the 
expression of NADPH oxidase, an oxidative stress marker, levels of proteinuria in the kidneys, 
and mesangial expansion were reduced, which showed that PC could prevent the incidence of 
diabetes in mice by reducing oxidative stress. ROS can increase the permeability of 
glomerulus as its concentration gradually increases, resulting in the deposition of plasma 
proteins in the basement membrane and causeing renal arteriosclerosis (Zheng et al., 2013). In 
canine kidney cells, PC can reduce oxalic acid-induced ROS and lipid peroxidation reactions, 
thereby preventing cells from the damage (Farooq et al., 2014). ROS also creates deposits in 
the extracellular matrix, causing expansion of mesangial area and damaging the kidneys. PC 
could prevent the cisplatin-induced decrease in glutathione reductase, decrease the levels of 
hydrogen peroxide, maintain the blood urea nitrogen at normal levels, and inhibit 
cisplatin-induced nephrotoxicity (Fernandez-Rojas et al., 2014). 
Lung disease: Two main factors cause oxidative stress in lung diseases. The first is 
exogenous factors such as smoke, environmental pollutants and chemicals. These compounds 
contain a large number of free radicals, which can directly stimulate the respiratory tract and 
lungs, causing cell and organ damage. Another is endogenous factors. Neutrophils in the 
pulmonary microcirculation can be activated, resulting in the release of large amounts of ROS 
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and causing cell and tissue damage. ROS can activate the signal pathway of NK-κB, 
exacerbate the inflammatory response, and directly stimulate the proliferation of fibroblasts to 
cause pulmonary fibrosis through factors such as TNF-α and ET-1 (Villegas et al., 2014). The 
herbicide Paraquat (PQ) is a highly toxic compound that causes pulmonary fibrosis. PC could 
inhibit the PQ-induced lipid peroxidation reaction, including increasing SOD activity and 
decreasing the MDA content to diminish its damage to cells and tissue in lungs, and 
improving the pathological damage induced by PQ (Sun et al., 2011). PC was also found to 
alleviate the TGF-β1 expression in lung tissue. Compared with the control group, the 
production of NF-κB p65 and TNF-α in the lungs was inhibited in the PQ-treated group. It has 
been suggested that PC possesses an anti-pulmonary fibrosis effect (Sun et al., 2012). 
Subsequently, the protective effect of PC on pulmonary fibrosis was found to involve 
protecting alveolar epithelial type I cells, alleviating fibroblast proliferation, and inhibiting the 
epithelial-mesenchymal transition (EMT) and oxidative stress. The PC-induced inhibition of 
the TLR2-MyD88-NF-κB signaling pathway in the early stages was very important for 
protection against pulmonary fibrosis (Li et al., 2017). 
Intestinal disease: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder. 
Although the etiology of IBD is unknown, currently there is consensus that ROS are involved 
in the induction and development of the disease. PC was used to treat acetic acid-induced 
ulcerative colitis in rats: Neutrophil infiltration was significantly reduced in rats with colitis 
after PC treatment. PC reduced the myeloperoxidase activity, inhibited inflammatory cell 
infiltration, and reduced colonic injury to some extent (Gonzalez et al., 1999). 
 
4.1.2. Anti-tumor properties 
Tumors result from the abnormal proliferation and differentiation of tissue cells when the 
body’s normal regulation of cell growth is disrupted. Much research has focused on 
developing anti-tumor drugs. However, most of existing synthetic anticancer drugs also have 
very strong toxic side-effect on normal cells of the human body. Studies have found that PBPs 
have inhibitory effect on a variety of tumors. 
 
4.1.2.1. In vitro studies of anti-tumor properties 
Thangam et al (2013) investigated the cytostatic effect of C-PC on cancer cells, and found 
C-PC inhibited the growth of HT-29 (colon cancer) and A549 (lung cancer) cells, as detected 
by fluorescence and phase contrast microscopies, arresting DNA replication in tumor cells. 
Recombinant APC has been found to be able to treat tumors. For example, recombinant APC 
inhibited H22 hepatoma cells significantly, and the inhibition rates ranged from 36% to 62% 
when the dose of PC was 6.25 to 50 mg/kg/day (Ge et al., 2005). The PE gene was 
successfully expressed in E. coli BL21, and tumor cytotoxicity assays showed that 
recombinant PE could inhibit the growth of HeLa cells, and the inhibition rate increased from 
37.3 to 63.26% as the protein concentration increased (Ruobing et al., 2007). These studies 
indicate that both native PBP and recombinant PBP have potential medical value in anti-tumor 
applications. 
 
4.1.2.2. In vivo studies of anti-tumor properties 
The therapeutic effect of C-PC on mouse skin tumors has been studied. Tumors were 
developed in mouse skin using 12-O-tetradecanoylphorbol-13-acetate (TPA), and 
tumor-specific factors, including ornithine decarboxylase, cyclooxygenase-2, and interleukin 
6, as well as phosphorylation signal transducers and activators of transcription 3, were 
detected in the mice with TPA-induced tumors, which were inhibited by C-PC in a 
dose-dependent manner (Gupta and Gupta, 2012). PBP not only reduces side-effects of 
anticancer drugs, but also increases their effectiveness. The drug topotecan used in 
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conjunction with PC was found to be more effective than topotecan treated alone at regular 
doses through activating a large number of caspase-9 and caspase-3 enzymes, and increased 
the effectiveness of topotecan treatment (Gantar et al., 2012). Although PBPs have an 
inhibitory effect on a variety of in vitro animal tumor models, their mechanism of action in 
inhibiting tumors is complex, and further research is needed. 
 
4.2. Optical applications 
PBPs can be used in photodynamic therapy and other fields, because PBPs can emit strong 
fluorescence after being irradiated with a laser (Table 5). 
 
Table 5 
 
4.2.1. Photodynamic therapy 
Photodynamic therapy is a new type of oncology therapy based on enriching a lesion area 
with photosensitizers, which cause oxidative damage to tumor tissue by generating free 
radicals and active oxygen species upon illumination. The selection of photosensitizers with 
high efficiency, low toxicity and good selectivity is the core of effective photodynamic 
therapy. 
As early in the 1980s, researchers found that PC could act as a cytotoxic photosensitizer. 
Examination of arterial sections by fluorescence microscopy revealed that PC can bind to 
human atherosclerotic plaques, enabling the plaque to be observed by fluorescence of PC 
(Morcos et al., 1988), which suggested a potential use of PC as a guide for photodynamic 
therapy. PC from Microcystis (MC-PC) has been studied for its photosensitization effect on 
HepG2 cells. After cancer cells were incubated with MC-PC, followed by laser irradiation, the 
cell viability was measured by the MTT method, and it was found that MC-PC at a dose of 
200 μg/mL effectively inhibited the growth of HepG2 under laser irradiation and induced 
apoptosis after 24 h, which identified a new source of PC from Microcystis as a safe and 
effective photosensitizer (Wang et al., 2012). C-PC was incubated with breast cancer cells 
MDA-MB-231, and the results showed that C-PC showed no photo-toxicity without laser 
irradiation, but when irradiated with a 625 nm laser, the cells were able to produce oxygen 
free radicals and ROS, leading to apoptosis and killing of MDA-MB-231 breast cancer cells 
(Bharathiraja et al., 2016). APC has a similar pigment structure to PC, and laser pulsed 
radiation technology has been used to characterize APC photochemical and photophysical 
transient intermediates. Under laser irradiation, APC is capable of generating triplet states and 
free radical cations, indicating that APC can perform photoexcitation and photoionization 
simultaneously, and can also be used as type I and type II photosensitizers (Suping et al., 
2001). 
PBPs have a stronger affinity for tumor cells than for normal cells, but the mechanism 
underlying this phenomenon is still unclear. In addition, because PBPs can also be used as a 
health food supplement to enhance immunity (Levi et al., 2018), some researchers believe that 
PBPs may have the effect of inhibiting tumor growth through a variety of synergistic effects. 
 
4.2.2. Fluorescence probes 
Much attention has been paid to the development of fluorescent probes based on PBPs as 
markers in immunohistochemistry, immunocytochemistry, flow cytometry, confocal laser 
microscopy, fluorescence-activated cell sorting, single-molecule detection, and other 
fluorescent immunoassays (Siiman et al., 1999; Guan et al., 2007). Companies such as 
Boehringer Ingelheim in Germany and Sigma and Molecular Probes in the USA have 
developed PBP-related probe products. 
APC is commonly used as a fluorescent probe to detect apoptosis (Tang et al., 2017; Li 
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et al., 2018). However, because of the stabilizing effect of its γ subunits, PE is the ideal 
fluorescent probe, and is more commonly used than other PBPs (Leney et al., 2018). 
Detection of IgG antibodies to Hendra virus in serum is important to help monitor outbreaks 
of the virus. The commonly used enzyme-linked immunosorbent assays and 
fluorescence-based Luminex assays typically consist of three steps, and take at least a few 
hours to complete the process. R-PE was used as a fluorescent label to bind directly to IgG 
protein, and because of the large specific surface area of the magnetic nanoparticles, it was 
possible to reduce each step in the detection process to 20 minutes (Gao et al., 2015). Using 
genetic engineering techniques and large-scale fermentation, recombinant PBPs can be 
produced at lower cost with improved fluorescence characteristics. Wu et al. (2017) 
co-expressed streptomycin and a fusion protein (SLA) from the APC α subunit of 
Thermosynechococcus elongatus BP-1, together with PEB synthase (Ho1 and PebS) or PCB 
synthetases (Ho1 and PcyA) in E. coli, and two recombinant PBPs (SLA-PEB and SLA-PCB) 
capable of binding biotin were obtained. The detection limits of these fusion proteins in tumor 
marker alpha-fetoprotein assays were 0.11 and 0.35 ng/mL, respectively. 
The extraction and purification of PBPs is difficult, and there is no mature process for 
industrial production, resulting in expensive products, and making it difficult to develop and 
apply PBP-based fluorescent probes. However, the characteristic fluorescence peak of some 
PBPs containing PCB is at 660 nm, which lies within visual imaging window for living tissue 
at 650~1100 nm (Shcherbo et al., 2007). Therefore, PBPs might be used as a development of 
near-infrared fluorescent probes. Higher organisms cannot biosynthesize PCB of PBPs, which 
greatly limits the application of the fluorescent proteins in mammalian cells, but mammalian 
cells are rich in heme, which can synthesize biliverdin (BV) under the catalysis of heme 
enzymes. The development of BV-based PBPs as near-infrared fluorescent probes has become 
a trend. 
 
5. Perspectives 
5.1. Assessment of structure and function of PBPs 
Since the last century, there has been much research on PBSs and PBPs and many 
high-resolution crystal structures of PBPs have been obtained. PBPs have a more complex 
structure and a more flexible type of assembly than other protein structures involved in 
photosynthesis. In the past decade, research on the energy transfer process of PBPs has 
progressed slowly because of the complexities of dynamic changes in the chromophore 
conformations and the intricate interaction between the chromophores and the 
microenvironment. With increasing knowledge of PBP structure and chromophore binding, it 
should be possible in the future to simulate the dynamic changes. PBSs usually contain 
hundreds of chromophores, and the energy delivery pathway is more complicated. Zhang et al 
(2017) solved the problem of the poor stability and orientation of PBSs during sample 
preparation and for the first time, reported the three-dimensional structure at a near-atomic 
resolution of an intact PBS which provides a basis for revealing the PBS assembly and light 
energy-transfer processes. 
More in-depth studies on the structure and energy transfer of PBPs, with techniques 
across physical and life sciences, including circular dichroism spectroscopy, transient 
spectroscopy, three-dimensional reconstruction technology using cryogenic electron 
microscopy, scanning tunneling microscope manipulation, and local electric field resonance 
enhancement regulation will enable the potential application of PBPs in many fields. Detailed 
studies of PBPs structure will help not only to understand the process of PBP self-assembly, 
but also to explore the relationship between the microenvironment and the spectroscopic 
properties of the phycobilin binding region. Studies of the structure of PBPs will also help to 
deepen the understanding of their anti-oxidative and other pharmaceutical activities. 
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5.2. Purification of PBPs on large scales at low cost 
The oceans are rich in seaweed resources, which provide a wealth of raw materials as a source 
for PBPs. However, the separation and purification processes are complicated and 
time-consuming with low recovery. At present, no efficient separation and purification 
methods have been found to yield high purity PBPs, which has greatly restricted their 
applications. How to develop fast and efficient extraction and purification technology to make 
the products with high purity and high recovery yield will remain the focus of future research. 
The preparation of natural PBPs from algae to study their light energy transfer mechanism for 
drug development is complicated, since natural PBPs often exist in the form of complexes. 
When used as drugs, their effects are often unpredictable. In the future, if high-density 
fermentation and high-level expression of recombinant PBPs can be achieved, not only will 
recombinant PBPs be produced on large scales, but also with improved quality. 
 
5.3. Mechanism underlying the pharmaceutical use of PBPs 
PBPs have potential pharmacological and biological uses, and may play an important 
therapeutic role in treating a variety of diseases such as atherosclerosis, hepatitis, pneumonia, 
and cataracts. Because PBPs can elicit allergic reactions with immune systems, they cannot be 
injected intravenously, and instead are orally administered. However, when PBPs enter the 
digestive system, they are broken down into amino acids, small peptides and phycobilins. 
Although the therapeutic effects of PBPs have been demonstrated, it is not clear how PBPs or 
their metabolites affect their targets and metabolic pathways, and mechanistic studies on the 
pharmacological effect of PBPs and their metabolites are thus needed, but little work has been 
done so far in this regard. Recently, we have observed the regulation of PC on mouse 
intestinal flora, and found that PC intervention promoted the colonization of beneficial 
bacteria and reduced intestinal permeability. Therefore, to evaluate the pharmacokinetic 
properties properly, it is necessary to detect PBPs and their main metabolites in blood and 
intestine. In addition, if the structure of the PBPs could be modified with improved activities, 
smaller and simpler mutant molecules may be obtained. In the future, PBP mutants are 
expected to help solve some current problems with the applications of PBPs. 
 
5.4. Applications of PBPs in optics 
With the completion of the whole genome sequencing of some algal species, more and more 
PBPs and chromophore lyases will be identified. Through construction of genetically 
engineered bacteria, production of recombinant PBPs with added molecular tags is possible, 
which not only solves problems with the preparation of fluorescent proteins, but also broadens 
the scope of their applications. For example, the use of solar energy in the bionic field might 
be expanded by establishing artificially directed evolutionary technology for PBPs and 
constructing efficient light-trapping devices for use under low light. Research into genetically 
recombinant PBPs has also laid material and technical foundations for the construction of 
PBP-based artificial solar energy capture devices. 
 
6. Conclusions  
PBPs have been studied for more than 50 years since Gantt and Conti first discovered them. 
Through the interplay of multiple disciplines, including structural biology, biochemistry, 
genetic engineering and computational biology, the molecular structures of PBPs have 
become increasingly clear while large-scale preparation techniques have also become more 
mature. In the future, commercial applications of high value-added products based on PBPs 
will be more promising with potentials for economic benefits. 
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Table legends 
Table 1. Aggregation states (in solution), spectral properties, and phycobilin composition of 
different PBPs. 
Table 2. Production of PBPs. 
Table 3. Some PBP lyases. 
Table 4. Pharmacological and biological properties of PBPs. 
Table 5. Optical applications of PBPs. 
 
Table 1 Aggregation states (in solution), spectral properties, and phycobilin composition of 
different PBPs. 
PBP 
Aggregation 
state 
Absorption peak 
and shoulder* 
(nm) 
Fluorescence 
peak(nm) 
Phycobilins References 
B-PE (αβ)6γ 545, 563*, 498* 575 12 α PEB, 18 β 
PEB, 2γ PUB， 2γ 
PEB 
(Fisher et al., 1980; 
Ficner et al., 1992; 
Tang et al., 2016) 
R-PE (αβ)6γ 498, 538, 567 578 12 α PEB, 12 β 
PEB, 6 β PUB, 2γ 
PUB， 1γ PEB 
(Jiang et al., 1999; Liu 
et al., 2005) 
C-PC (αβ)3 616 643 3 α PCB, 6 β PCB (Padyana et al., 2001; 
Wang et al., 2001; 
Kumar et al., 2014) 
R-PC (αβ)3 549*, 617 636 
 
3 α PCB, 3 β PEB, 
3 β PCB 
(Jiang et al., 2001; 
Wang et al., 2014) 
PEC (αβ)3 530*, 575, 595* 625 
 
3 α PXB, 6 β PCB (Nies and Wehrmeyer, 
1980; Rumbeli et al., 
1985; Duerring et al., 
1990) 
APC (αβ)3 650, 618* 663 3 α PCB, 6 β PCB (Brejc et al., 1995; 
Chethana et al., 2015) 
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Table 2 Production of PBPs. 
PBP Source 
Cell disruption 
and crude PBP 
extraction 
Purification of PBPs Purity Yield References 
PC Spirulina 
platensis (dry) 
Sonication Aqueous two-phase 
extraction 
- - (Chang et al., 
2018) 
PC Arthrospira 
platensis (dry) 
Sonication 
Rreezing and 
thawing 
Ammonium sulfate 
fractionation (25-70) 
Ion exchange 
chromatography 
2.5 - (Kissoudi et 
al., 2018) 
PC Synechococcus 
sp. R42DM 
Triton-X 100 
treatment 
Sonication 
Ammonium sulfate 
Fractionation20-70 
Ion-exchange 
chromatography 
4.03 - (Sonani et al., 
2017) 
PC Spirulina 
platensis 
Homogenized Aqueous two-phase 
extraction 
4.32 79% (Chethana et 
al., 2015) 
PC Spirulina 
platensis 
Freezing and 
thawing 
Ammonium sulfate 
fractionation  
Anion exchange 
chromatography 
4.5 14% (Kumar et al., 
2014) 
PC Limnotrhrix sp Freeze–thawed Activated carbon and 
chitosan treatment 
Ammonium sulfate 
fractionation  
tangential flow filtration 
4.3 8% (Gantar et al., 
2012) 
PC Spirulina 
platensis 
Freeze–thawed Ammonium sulfate 
fractionation  
High-speed counter-current 
chromatography 
4.25 - (Yin et al., 
2011) 
PC Synechocystis 
aquatilis 
Osmotic shock Expanded bed 
chromatography 
Anion-exchange 
chromatography 
4.0 69% (Ramos et al., 
2011) 
PC Spirulina 
platensis 
Homogenized Anion-exchange 
chromatography 
1.82 77.3
% 
(Silveira et 
al., 2008) 
PC Phormidium 
fragile 
Grinding under 
liquid nitrogen 
Ammonium sulfate 
fractionation 
Hydrophobic interaction 
Chromatography 
4.52 - (Soni et al., 
2008b) 
PC Spirulina 
platensis 
Ammonium 
sulfate treatment 
Expanded bed adsorption 
Chromatography 
Anion-exchange 
chromatography 
Hydroxyapatite 
chromatography 
3.2 - (Niu et al., 
2007b) 
PC 
and 
APC 
Arthronema 
africanum 
Freeze–thawed  Rivanol treatment 4.52 
and 
2.41 
55%  
and  
35% 
(Minkova et 
al., 2007) 
PC Spirulina 
platensis 
Homogenized by 
press 
Aqueous two-phase 
extraction 
4.05 85% (Patil et al., 
2006) 
PC Spirulina 
platensis 
Klebsiella 
neumoniae 
treatment 
- 1.09 91% (Zhu et al., 
2007) 
PC Spirulina 
platensis 
Freezing and 
thawing  
Sonication 
Ammonium sulfate 
fractionation  
Ion-exchange 
chromatography  
5.12 - (Chen et al., 
2006) 
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Gel filtration 
chromatography 
PC Spirulina 
platensis 
Homogenized at 
a pressure 
Aqueous two phase 
extraction 
Ion-exchange 
chromatography 
6.69 - (Patil et al., 
2006) 
PC Aphanizomeno
n flos-aquae 
- Ammonium sulfate 
fractionation  
Hydroxyapatite 
chromatography 
4.78 - (Benedetti et 
al., 2006) 
PC Spirulina Freezing and 
thawing  
Sonication 
Ion-exchange 
chromatography 
4.42 45.6
% 
(Patel et al., 
2005b) 
PC Phormidium sp. Freezing and 
thawing  
Sonication 
Ion-exchange 
chromatography 
4.43 35.2
% 
(Patel et al., 
2005b) 
PC Lyngbya sp. Freezing and 
thawing  
Sonication 
Ion-exchange 
chromatography 
4.59 36.8
% 
(Patel et al., 
2005b) 
PC Calothrix sp. EDTA and 
Lysozyme 
treatment 
Anion chromatography 
Hydrophobic interaction 
Chromatography 
3.5 80% (Santiago-San
tos et al., 
2004) 
PC Spirulina 
fusiformis 
Freezing and 
thawing 
Rivanol treatment 
Gel filtration 
chromatography 
4.3 46% (Minkova et 
al., 2003) 
PC Spirulina 
maxima 
Glass beads 
milling 
Aqueous two phase 
extraction 
Ultrafiltration 
Precipitation 
3.8 29.5 (Rito 
Palomares et 
al., 2001) 
PC 
and 
APC 
Spirulina 
platensis 
Freezing and 
thawing  
Sonication 
Ammonium sulfate 
fractionation  
Ion exchange 
chromatography 
Gel filtration 
chromatography 
5.06 
and 
5.34 
- (Zhang and 
Chen, 1999) 
APC Spirulina 
platensis 
Freezing and 
thawing 
Ammonium sulfate 
fractionation  
Hydroxylapatite extraction 
Anion-exchange 
chromatography 
5.0 43% (Su et al., 
2010) 
C-PE Pseudanabaena 
sp. 
Freezing and 
thawing 
Ammonium sulfate 
fractionation  
Gel filtration 
Ion exchange 
chromatography 
6.86 47% (Mishra et al., 
2011) 
C-PC 
and 
APC 
Spirulina 
platensis 
Frozen and 
thawed 
Ammonium sulfate 
fractionation  
Ion exchange 
chromatography 
5.59 
and 
5.19 
67% 
and 
80% 
(Yan et al., 
2011) 
B-PE 
and 
R-PC 
Porphyridium 
cruentum 
Homogenized 
Sonicated 
Ammonium sulfate 
fractionation 
Ion exchange 
chromatography 
>4 
and >3 
32% 
and 
12% 
(Bermejo et 
al., 2002) 
B-PE Porphyridium 
cruentum 
Buffer extraction 
from lyophilized 
alga 
Expanded-bed adsorption 
Chromatography 
Ion-exchange 
chromatography 
4.6 66% (Bermejo et 
al., 2003) 
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R-PE Polysiphonia 
urceolata 
Freezing and 
thawing 
Ammonium sulfate 
fractionation 
Anion-exchange 
Chromatography 
5.6 67.3
% 
(Liu et al., 
2005) 
R-PE Polysiphonia 
urceolata 
Osmotic shock Expanded-bed adsorption 
Chromatography 
Ion exchange 
chromatography or 
hydroxyapatite 
Chromatography 
3.26 - (Niu et al., 
2006) 
R-PE Porphyra 
haitanensis 
Freeze-thaw Expanded-bed columns 
Anion-exchange 
3.2 - (Niu et al., 
2007) 
R-PE Portieria 
hornemannii 
Freezing and 
thawing 
Ammonium sulfate 
fractionation  
Anionic-exchange 
5.2 64.8
% 
(Senthilkumar 
et al., 2013) 
R-PE Grateloupia 
turuturu 
Liquid nitrogen 
grinding 
Anion-exchange 
chromatography 
2.89 27% (Munier et al., 
2015) 
B-PE Porphyridium 
cruentum 
Osmotic shock Ultrafiltration 
Anion-exchange 
chromatography 
5.1 68.5
% 
(Tang et al., 
2016b) 
R-PE Gracilaria 
lemaneiformis 
Osmotic shock 
refined 
Ammonium sulfate 
fractionation  
Centrifugal precipitation 
Chromatography 
6.5 - (Gu et al., 
2018) 
PC Galdieria 
sulphuraria 
Homogenized Ammonium sulfate 
fractionation  
Aqueous two-phase 
extraction 
Anion exchange 
Chromatography 
4.5 39% (Sorensen et 
al., 2013) 
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Table 3 Some PBP lyases. 
Lys 
gene 
Gene source Catalytic site Reference 
cpcE/F Synechococcus PCC 
7002 
PCB→PC α-Cys-84 (Fairchild et al., 1992) 
Synechocystis sp. PCC 
6803 
PCB→CPC α (Tooley et al., 2001) 
Synechocystis sp. PCC 
6803 
PCB→APC α (Yang et al., 2008) 
pecE/F Nostoc PCC 7120, 
Mastigocladus 
laminosus 
PVB→PEC α-Cys-84 (Storf et al., 2001; Zhao et al., 
2002) 
cpeY/Z Algae containing PE PEB→PE α（PEsI） (Kahn et al., 1997) 
cpcS/U Synechococcus PCC 
7002 
- (Miller et al., 2008; Saunee et 
al., 2008; Shen et al., 2008) 
cpeS Anabaena sp. PCC 7120 APC β (Ge et al., 2009) 
cpeS1 Anabaena PCC 7120 PCB→Apophycophytin (Zhao et al., 2007) 
cpeS2 Nostoc PCC 7120 CPC β-Cys-84 (Zhao et al., 2007) 
cpcT Synechocystis sp. PCC 
7002 
CPC β-Cys-153 (Shen et al., 2006) 
MpeV/U Algae containing PE PEB→PE α（PEsII） (Zhao et al., 2007) 
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Table 4 Pharmacological and biological properties of PBPs. 
Protein or gene source PBP 
Pharmacological and biological 
properties 
References 
Arthospira maxima PC Antioxidant (Romay et al., 1998) 
Arthospira maxima C-PC Antioxidant,  
Anti-inflammatory ability 
(Romay et al., 1998) 
AfaMax PC Antioxidant,  
Anti-inflammatory ability 
(Castangia et al., 2016) 
- C- PC Antioxidant, Reduce 
osteoarthritis 
(Young et al., 2016) 
- C- PC Antioxidant, Antihyperlipidemic (Sheu et al., 2013) 
Spirulina maxima 
(Dried marine micro alga) 
C- PC Antioxidant,  
Anti-inflammation activities 
(Choi and Lee, 2018) 
Portieria homemannii R-PE Antioxidant, Vitro anticancer (Senthilkumar et al., 
2013) 
Synechococcus sp PC Antioxidant,  
Radical-scavenging activity 
(Sonani et al., 2017) 
Spirulina platensis C- PC Anti-inflammatory ability (Chen et al., 2014) 
Limnothrix sp strain 
37-2-1 
C- PC Antioxidant (Gantar et al., 2012) 
Lyngbya sp. A09DM PE Antioxidant (Sonani et al., 2014) 
Spirulina PC Antioxidant (Romay and Gonzalez, 
2000) 
Spirulina platensis Apo-c-PC β 
subunit and 
C-PC 
Antioxidant (Pleonsil et al., 2013) 
Spyrulina species C- PC Antioxidant (Lissi et al., 2000) 
Spirulina fussiformis C- PC Antioxidant (Madhyastha et al., 2009) 
Spirulina platensis Selenium-con
taining 
PC 
Antioxidant (Huang et al., 2007) 
Aphanizomenon 
flos-aquae 
PC Antioxidant (Benedetti et al., 2004) 
MaterialsS. maxima PC Antioxidant (Nakagawa et al., 2016) 
Spirulina platensis Se-APC Antioxidant, 
Inhibition of cancer cells 
(Fan et al., 2012) 
Anacystis nidulans 
UTEX 625 
Recombinant 
APC 
Antioxidant (Ge et al., 2006) 
Spirulina platensis Recombinant 
α-PC 
Antioxidant (Guan et al., 2009) 
Porphyra haitanensis R- PC Anti-allergy, 
Anti-inflammation activities 
(Liu et al., 2015) 
Spirulina platensis C- PC Decrease the blood glucose 
level 
(Setyaningsih et al., 
2015; Ou et al., 2016) 
Spirulina platensis C- PC Anti-atherosclerosis (Riss et al., 2007; Strasky 
et al., 2013) 
Spirulina maxima C- PC Reduce liver damage (Ou et al., 2010) 
Spirulina platensis C- PC Reduce liver damage (Pak et al., 2012; Hussein 
et al., 2015; Xia et al., 
2016) 
Arthlpira maxima SAG 
25780 
C- PC Reduce liver damage (Nagaraj et al., 2012) 
Spirulina platensis C- PC Cataract treatment (Kothadia and 
Shabaraya, 2011; Kumari 
et al., 2013) 
Spirulina (Arthospira) 
species 
C- PC Reduce nerve damage (Rimbau et al., 1999) 
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Spirulina platensis C- PC Reduce nerve damage (Bermejo-Bescos et al., 
2008; Min et al., 2015; 
Mitra et al., 2015) 
- PC Reduce neurodegenerative 
diseases associated with 
proteotoxicity, 
(Macedo et al., 2017) 
Spirulina platensis PC and PCB Protect kidneys (Zheng et al., 2013) 
Spirulina platensis C- PC Protect kidneys (Farooq et al., 2014; 
Fernandez-Rojas et al., 
2014) 
Spirulina platensis C- PC Reduces pulmonary fibrosis (Sun et al., 2011; Sun et 
al., 2012; Li et al., 2017) 
Bangioatropurpurea R-PC Alleviates allergic airway 
inflammation 
(Chang et al., 2011) 
Spirulina platensis C- PC Antifibrotic (Pattarayan et al., 2017) 
Arthospira maxima C- PC Reduce intestinal inflammation (Gonzalez et al., 1999) 
Spirulina platensis APC Reduce intestinal damage (Chueh, 2002; Shih et al., 
2003) 
Spirulina (Dry powder) C- PC Anti-tumor (Gupta and Gupta, 2012) 
Spirulina platensis C- PC Anti-tumor (Gantar et al., 2012; Saini 
et al., 2012; Saini and 
Sanyal, 2014; Li et al., 
2015; Deniz et al., 2016) 
Oscillatoria tenuis C- PC Anti-tumor (Thangam et al., 2013) 
Anacystis nidulans 
UTEX625 
Recombinant 
APC 
Inhibition of cancer cells (Ge et al., 2005; Ge et al., 
2005) 
Gracilaria lemaneiformis PE Inhibition of cancer cells (Ruobing et al., 2007) 
Spirulina platensis C- PC Inhibition of cancer cells (Pan et al., 2015; Ying et 
al., 2016) 
Spirulina powder Digestion by 
pepsin 
releases 
biologically 
active 
chromopeptid
es from C-PC 
Antioxidant, 
Inhibition of cancer cells 
(Minic et al., 2016) 
Oscillatoria tenuis C- PC Antioxidant, 
Inhibition of cancer cells 
(Thangam et al., 2013) 
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Table 5 Optical applications of PBPs. 
Protein or gene 
source 
PBP Application References 
- APC Photodynamic therapy (Suping et al., 2001) 
Microcystis PC Photodynamic therapy (Wang et al., 2012) 
Spirulina 
platensis 
C- PC Photodynamic therapy (Bharathiraja et al., 
2016) 
- R-PE Photodynamic therapy (Huang et al., 2002) 
Spirulina C- PC High efficient fluorescence 
sensors 
(Wang et al., 2016) 
- C- PC Fluorescence probe (Han et al., 2018) 
- PBP Fluorescence probe (Siiman et al., 1999) 
Gastroclonium 
coulteri 
(Rhodymeniales) 
R-PE Fluorescence probe (Oi et al., 1982) 
- R-PE Fluorescence probe (Gao et al., 2015) 
- APC Fluorescence probe (Tang et al., 2017; Li et 
al., 2018) 
Streptomyces 
avidinii 
Recombinant fusion PBP 
(SLA-PEB and SLA-PCB) 
Fluorescence probe (Wu et al., 2017) 
Synechococcus 
sp pcc 6803 
Streptavidin-PBPs 
(SA-PBPs) 
Immunoassay technologies (Ge et al., 2017) 
Chroococcidiops
is thermalis 
ApcF2 
(The phycobilisome core 
subunit) 
Fluorescent markers (Ding et al., 2017) 
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Figure captions 
 
Fig. 1. Absorbance spectra of B-PE, R-PE, C-PC, APC, Chla, and Chlb. 
 
Fig. 2. Applications of PBPs (for details see in Tables 4 and 5). 
 
 
Fig. 1. Absorbance spectra of B-PE, R-PE, C-PC, APC, Chla, and Chlb. 
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Fig. 2. Applications of PBPs (for details see in Tables 4 and 5). 
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